2020
DOI: 10.1099/jgv.0.001405
|View full text |Cite
|
Sign up to set email alerts
|

Coexpression of soluble and membrane-bound avian influenza virus H5 by recombinant Newcastle disease virus leads to an increase in antigen levels

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 48 publications
0
6
0
Order By: Relevance
“…NDV constructs bearing genes encoding the SARS-CoV S protein [ 28 ] and the SARS-CoV-2 S protein [ 27 ], both around 3.8 kb in size, have been successfully generated, demonstrating this vector’s capacity for inserts in this size range. NDV has also been shown to tolerate multiple transgenes [ 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ] using different co-expression strategies [ 59 ]. Each foreign gene must be flanked by untranslated regions (UTRs) of NDV genes called gene start (GS) and gene end (GE) sequences ( Figure 1 ).…”
Section: Designing and Generating Recombinant Ndvmentioning
confidence: 99%
See 1 more Smart Citation
“…NDV constructs bearing genes encoding the SARS-CoV S protein [ 28 ] and the SARS-CoV-2 S protein [ 27 ], both around 3.8 kb in size, have been successfully generated, demonstrating this vector’s capacity for inserts in this size range. NDV has also been shown to tolerate multiple transgenes [ 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ] using different co-expression strategies [ 59 ]. Each foreign gene must be flanked by untranslated regions (UTRs) of NDV genes called gene start (GS) and gene end (GE) sequences ( Figure 1 ).…”
Section: Designing and Generating Recombinant Ndvmentioning
confidence: 99%
“…Similar to vaccine candidates for human use, several NDV vaccines expressing multiple antigens have been developed for veterinary use either by co-expressing the antigens within the same vector [ 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ] or by inoculating different vectors, each expressing a different antigen, in the same formulation [ 71 , 86 , 93 , 94 ]. For the latter, two studies have found that a formulation with only one vector/antigen yielded better results and sufficient protection [ 86 , 93 ], while another study found adequate immune responses regardless of inoculating one or multiple vectors [ 71 ].…”
Section: Ndv-vectored Vaccinesmentioning
confidence: 99%
“…However, recent results verified that modification of GOI expression pattern is an effective means to overcome the inhibition by GOI MDA. Soluble and membrane-bound H5 HAs were coexpressed in a recombinant NDV (rNDVsolH5_H5), resulting in a significant increase in antigen levels (Murr et al, 2020b). They speculated that elevated antigen levels may enhance antigenicity of HA, which may overwhelm the interference of AIV-MDA.…”
Section: Expression Of Soluble Antigens In Ndv Vector As Decoysmentioning
confidence: 99%
“…Sufficient amounts of the antigens in these two forms are required to absorb high proportions of MDA and to stimulate protective antibody immune response, respectively. In Murr's work, the soluble and FL HA were inserted between the P-M and F-HN genes, which resulted in 5.25-fold increase in total HA expression level (Murr et al, 2020b). Other combinations of the insertion sites in NDV genome for the GOI should be further evaluated.…”
Section: Efficacy Of Virus Vectors Expressing Soluble Antigens: No Consensus Yetmentioning
confidence: 99%
See 1 more Smart Citation